Skip to main content

Advertisement

SpringerLink
Log in

Recombinant Parathyroid Hormone in the Management of Osteoporosis

  • Review
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. E Bauer J Aub F Albright (1929) ArticleTitleStudies of calcium and phosphorus metabolism. V. A study of the bone trabeculae as a readily available reserve supply of calcium J Exp Med 49 145–162 Occurrence Handle10.1084/jem.49.1.145

    Article  Google Scholar 

  2. J Reeve (1996) ArticleTitlePTH: a future role in the management of osteoporosis J Bone Miner Res 11 440–445 Occurrence Handle8992874

    PubMed  Google Scholar 

  3. DN Kalu J Pennock FH Doyle GV Foster (1971) ArticleTitleParathyroid hormone and experimental osteosclerosis Lancet i 1363–1366

    Google Scholar 

  4. J Reeve PJ Meunier JA Parsons M Bernat OLM Bijvoet P Courpron CM Edouard L Klenerman RM Neer JC Renier D Slovik FJFE Vismans JT Potts (1980) ArticleTitleAnabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial B Med J 280 1340–1344

    Google Scholar 

  5. RM Neer CD Arnaud JR Zanchetta R Prince GA Gaich J-Y Reginster AB Hodsman EF Eriksen S Ish-Shalom HK Genant O Wang B Mitlak (2001) ArticleTitleEffect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis New Engl J Med 344 1434–1441 Occurrence Handle10.1056/NEJM200105103441904 Occurrence Handle11346808

    Article  PubMed  Google Scholar 

  6. Y Jiang JJ Zhao BH Mitlak O Wang HK Genant EF Eriksen (2003) ArticleTitleRecombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure J Bone Miner Res 18 1932–1941 Occurrence Handle14606504

    PubMed  Google Scholar 

  7. A Iida-Klein H Zhou SS Lu LR Levine M Ducayen-Knowles D Dempster J Nieves R Lindsay (2002) ArticleTitleAnabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice J Bone Miner Res 17 808–816 Occurrence Handle12009011

    PubMed  Google Scholar 

  8. JM Hock (2001) ArticleTitleAnabolic actions of PTH in the skeleton of animals J Musculoskel Neuron Interact 2 33–47

    Google Scholar 

  9. AB Hodsman B Steer (1993) ArticleTitleEarly histomorphometric changes in response to parathyroid hormone in osteoporosis: evidence for de novo bone formation on quiescent surfaces Bone 14 523–527 Occurrence Handle10.1016/8756-3282(93)90190-L Occurrence Handle8363903

    Article  PubMed  Google Scholar 

  10. DW Dempster F Cosman ES Kurland H Zhou J Nieves L Woelfert E Shane K Plavetic R Müller JP Bilezikian R Lindsay (2001) ArticleTitleEffects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study J Bone Miner Res 16 1846–1853 Occurrence Handle11585349

    PubMed  Google Scholar 

  11. DW Dempster H Zhou F Cosman J Nieves JD Adachi LJ Fraher PH Watson R Lindsay AB Hodsman (2001) ArticleTitlePTH treatment directly stimulates bone formation in cancellous and cortical bone in humans J Bone Miner Res 16 S179

    Google Scholar 

  12. AM Parfitt (2002) ArticleTitlePerspective. Parathyroid hormone and periosteal bone expansion J Bone Miner Res 17 1741–1743 Occurrence Handle12369776

    PubMed  Google Scholar 

  13. JR Zanchetta CE Bogado JL Ferretti O Wang MG Wilson M Sato GA Gaich GP Dalsky SL Myers (2003) ArticleTitleEffects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis J Bone Miner Res 18 539–543 Occurrence Handle12619939

    PubMed  Google Scholar 

  14. DB Burr T Hirano CH Turner C Hotchkiss R Brommage JM Hock (2001) ArticleTitleIntermittently administered human parathyroid hormone (1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomised cynomolgus monkeys J Bone Miner Res 16 157–165 Occurrence Handle11149480

    PubMed  Google Scholar 

  15. RL Jilka RS Weinstein T Bellido P Robertson AM Parfitt SC Manolagas (1999) ArticleTitleIncreased bone formation by prevention of osteoblast apoptosis with PTH J Clin Invest 104 439–446 Occurrence Handle10449436

    PubMed  Google Scholar 

  16. JM Hock V Krishnan JE Onyia JP Bidwell J Milas D Stanilaus (2001) ArticleTitlePerspective. Osteoblast apoptosis and bone turnover J Bone Miner Res 16 975–984 Occurrence Handle11393794

    PubMed  Google Scholar 

  17. J-J Body GA Gaich WH Scheele PM Kulkarni PD Miller A Peretz RK Dore R Correa-Rotter A Papaioannou DC Gumming AB Hodsman (2002) ArticleTitleA randomised double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis J Clin Endocrinol Metab 87 4528–4535 Occurrence Handle10.1210/jc.2002-020334 Occurrence Handle12364430

    Article  PubMed  Google Scholar 

  18. DM Black SL Greenspan KE Ensrud L Palermo JA McGowan TF Lang P Garnero ML Bouxsein JP Bilezikian CJ Rosen (2003) ArticleTitleThe effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis New Engl J Med 349 1207–1215 Occurrence Handle10.1056/NEJMoa031975 Occurrence Handle14500804

    Article  PubMed  Google Scholar 

  19. ES Orwoll WH Scheele S Paul S Adami U Syversen A Diez-Perez JM Kaufman AD Clancy GA Gaich (2003) ArticleTitleThe effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis J Bone Miner Res 18 9–17 Occurrence Handle12510800

    PubMed  Google Scholar 

  20. AB Hodsman BM Steer LJ Fraher DJ Drost (1991) ArticleTitleBone densitometric and histomorphometric responses to sequential human parathyroid hormone (1-38) and salmon calcitonin in osteoporotic patients Bone Miner 14 67–83 Occurrence Handle10.1016/0169-6009(91)90103-7 Occurrence Handle1868270

    Article  PubMed  Google Scholar 

  21. RM Neer DM Slovik M Daly JT Potts SR Nussbaum (1993) ArticleTitleTreatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol Osteoporos Int 3 204–205 Occurrence Handle10.1007/BF01621907

    Article  Google Scholar 

  22. R Lindsay J Nieves CA Formica E Henneman L Woelfert V Shen DW Dempster F Cosman (1997) ArticleTitleRandomised controlled study of effects of parathyroid hormone on vertebral bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis Lancet 350 550–555 Occurrence Handle10.1016/S0140-6736(97)02342-8 Occurrence Handle9284777

    Article  PubMed  Google Scholar 

  23. JS Finkelstein A Klibanski AL Arnold TL Toth RM Neer (1998) ArticleTitlePrevention of estrogen deficiency related bone loss with human parathyroid hormone (1-34): a randomised controlled trial JAMA 280 1067–1076 Occurrence Handle10.1001/jama.280.12.1067 Occurrence Handle9757854

    Article  PubMed  Google Scholar 

  24. AB Hodsman DA Hanley MP Ettinger MA Bolognese J Fox AJ Metcalfe R Lindsay (2003) ArticleTitleEfficacy and safety of human parathyroid hormone-(l-84) in increasing bone mineral density in postmenopausal osteoporosis J Clin Endocrinol Metab 88 5212–5220 Occurrence Handle10.1210/jc.2003-030768 Occurrence Handle14602752

    Article  PubMed  Google Scholar 

  25. R Marcus O Wang J Satterwhite B Mitlak (2003) ArticleTitleThe skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis J Bone Miner Res 18 18–23 Occurrence Handle12510801

    PubMed  Google Scholar 

  26. Forsteo Summary of product characteristics

  27. BM Misof P Roschger F Cosman ES Kurland W Tesch P Messmer DW Dempster J Nieves E Shane P Fratzl K Klaushofer JP Bilezikian R Lindsay (2003) ArticleTitleEffects of intermittent parathyrouid hormone administration on bone mineralisation density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment J Clin Endocrinol Metabol 88 1150–1156 Occurrence Handle10.1210/jc.2002-021988

    Article  Google Scholar 

  28. JL Vahle M Sato GG Long JK Young PC Francis JA Engelhardt M Westmore L Ma JB Nold (2002) ArticleTitleSkeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety Toxicol Pathol 30 312–321 Occurrence Handle10.1080/01926230252929882 Occurrence Handle12051548

    Article  PubMed  Google Scholar 

  29. PC Jutte R Rosso M Paolis Particlede C Errani E Pasini L Campanacci G Bacci F Bertoni M Mercuri (2004) ArticleTitleOsteosarcoma associated with hyperparathyroidism Skeletal Radiol 33 473–476 Occurrence Handle10.1007/s00256-004-0771-0 Occurrence Handle15160256

    Article  PubMed  Google Scholar 

  30. AH Tashjian BA Chabner (2002) ArticleTitlePerspective. Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal women J Bone Miner Res 17 1151–1161 Occurrence Handle12096828

    PubMed  Google Scholar 

  31. NE Lane S Sanchez GW Modin HK Genant CD Arnaud (1998) ArticleTitleParathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled trial J Clin Invest 102 1627–1633 Occurrence Handle9788977

    PubMed  Google Scholar 

  32. NE Lane S Sanchez GW Modin HK Genant E Pierini CD Arnaud (2000) ArticleTitleBone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial J Bone Miner Res 15 944–951 Occurrence Handle10804025

    PubMed  Google Scholar 

  33. JM Hock J Hummert R Boyce J Fonseca LG Raisz (1989) ArticleTitleResorption is not essential for the stimulation of bone formation by human PTH 1-34 in rats in vivo J Bone Miner Res 4 449–458 Occurrence Handle2527459

    PubMed  Google Scholar 

  34. PD Delmas P Vergnaud ME Arlot P Pastoureau PJ Meunier MHL Nilssen (1995) ArticleTitleThe anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate —is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodelling system? Bone 16 603–610 Occurrence Handle10.1016/8756-3282(95)00113-R Occurrence Handle7669436

    Article  PubMed  Google Scholar 

  35. JS Finkelstein A Hayes JL Hunzelman JJ Wyland H Lee RM Neer (2003) ArticleTitleThe effects of parathyroid hormone, alendronate, or both in men with osteoporosis N Engl J Med 349 1216–1226 Occurrence Handle10.1056/NEJMoa035725 Occurrence Handle14500805

    Article  PubMed  Google Scholar 

  36. F Cosman J Nieves L Woelfert CA Formica SL Gordon V Shen R Lindsay (2001) ArticleTitleParathyroid hormone added to established hormone replacement therapy: effects on vertebral fracture and maintenance of bone mass after parathyroid hormone withdrawal J Bone Miner Res 16 925–931 Occurrence Handle11341338

    PubMed  Google Scholar 

  37. F Cosman J Nieves L Woelfert V Shen R Lindsay (1998) ArticleTitleAlendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic woman J Bone Miner Res 13 1051–1055 Occurrence Handle9626638

    PubMed  Google Scholar 

  38. B Ettinger J San Martin G Grans I Pavo (2004) ArticleTitleDifferential effects of teriparatide on BMP after treatment with raloxifene or alendronate J Bone Miner Res 19 745–751 Occurrence Handle15068497

    PubMed  Google Scholar 

  39. RS Rittmaster M Bolognes MP Ettinger DA Hanley AD Hodsman DL Kendler CJ Rosen (2000) ArticleTitleEnhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate J Clin Endocrinol Metab 85 2129–2134 Occurrence Handle10.1210/jc.85.6.2129 Occurrence Handle10852440

    Article  PubMed  Google Scholar 

  40. R Lindsay W Scheele N Neer G Pohl S Adami C Mautalen J-Y Reginster JJ Stepan SL Myers BH Mitlak (2004) ArticleTitleSustained vertebral fracture risk reduction after withdrawal of teriparatide in postmenopausal women with osteoporosis Arch Intern Med 164 2024–2030 Occurrence Handle10.1001/archinte.164.18.2024 Occurrence Handle15477438

    Article  PubMed  Google Scholar 

  41. DM Black SR Cummings DB Karpf JA Cauley DE Thompson MC Nevitt DC Bauer HK Genant WL Haskell R Marcus SM Ott JC Torner SA Quandt TF Reiss KE Ensrud (1996) ArticleTitleRandomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures Lancet 348 1535–1541 Occurrence Handle10.1016/S0140-6736(96)07088-2 Occurrence Handle8950879

    Article  PubMed  Google Scholar 

  42. B Ettinger DM Black BH Mitlak RK Knickerbocker T Nickelsen HK Genant C Christiansen PD Delmas JR Xanchetta J Stakkestad CC Glüer K Krueger FJ Cohen S Eckert KE Ensrud LV Avioli P Lips SR Cummings (1999) ArticleTitleReduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial JAMA 282 637–645 Occurrence Handle10.1001/jama.282.7.637 Occurrence Handle10517716

    Article  PubMed  Google Scholar 

  43. ST Harris NB Watts HK Genant CD McKeever T Hangartner M Keller CH Chesnut J Brown EF Eriksen MS Hoseyni DW Axelrod PD Miller (1999) ArticleTitleEffects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis. A randomized controlled trial JAMA 282 1344–1352 Occurrence Handle10.1001/jama.282.14.1344 Occurrence Handle10527181

    Article  PubMed  Google Scholar 

  44. J-Y Reginster HW Minne OH Sorensen M Hooper C Roux ML Brandi B Lund D Ethgen S Pack I Roumagnac R Eastell InstitutionalAuthorName on behalf of the Vertebral Efficacy with Risedronate Therapy (VERT) Study Group (2000) ArticleTitleRandomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis Osteoporos Int 11 83–91 Occurrence Handle10.1007/s001980050010 Occurrence Handle10663363

    Article  PubMed  Google Scholar 

  45. CH Chesnut S Silverman K Andriano HK Genant A Gimona S Harris D Kiel M LeBoff M Maricic N Watts D Baylink (2000) ArticleTitleA randomised trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the Prevent Recurrence of Osteoporotic Fractures Study Am J Med 109 267–276 Occurrence Handle10.1016/S0002-9343(00)00490-3 Occurrence Handle10996576

    Article  PubMed  Google Scholar 

  46. PJ Meunier C Roux E Seeman S Ortolani JE Badurski TD Spector J Cannata A Balogh EM Lemmel S Pors-Nielsen R Rizzoli HK Genant JY Reginster (2004) ArticleTitleThe effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis N Engl J Med 350 459–468 Occurrence Handle10.1056/NEJMoa022436 Occurrence Handle14749454

    Article  PubMed  Google Scholar 

  47. MR McClung P Geusens PD Miller H Zippel WG Benson C Roux S Adami I Fogelman T Diamond R Eastell PJ Meunier J-Y Reginster (2001) ArticleTitleEffect of risedronate on the risk of hip fracture in elderly women N Engl J Med 344 333–340 Occurrence Handle10.1056/NEJM200102013440503 Occurrence Handle11172164

    Article  PubMed  Google Scholar 

  48. JY Reginster E Seeman MC DeVernejoul S Adami J Compston C Phenekos JP Devogelaer M Diaz-Curiel A Sawicki S Goemare OH Sorensen D Felsenberg PJ Meunier (2005) ArticleTitleStrontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of peritoneal osteoporosis (TROPOS) study. J Clin Endocrinol Metab 90 2816 Occurrence Handle10.1210/jc.2004-1774 Occurrence Handle15728210

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke’s Hospital Hills Road, Box 157, CB2 2QQ, Cambridge , UK

    J. Compston

Authors
  1. J. Compston
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Compston.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Compston, J. Recombinant Parathyroid Hormone in the Management of Osteoporosis. Calcif Tissue Int 77, 65–71 (2005). https://doi.org/10.1007/s00223-005-0012-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-005-0012-0

Keywords

Search

Navigation